Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study.
Justin Basile Echouffo-TcheuguiSui ZhangRoberta FloridoJames S PankowErin Donelly MichosRonald B GoldbergVijay NambiGary GerstenblithWendy S PostRoger Scott BlumenthalChristie M BallantyneJosef CoreshElizabeth SelvinChiadi E NdumelePublished in: Journal of the American Heart Association (2024)
MetS and diabetes are associated with elevated Gal-3. The HF risk significantly increased with the combination of greater metabolic risk and higher Gal-3.